The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents
Open accessAbstract
Background: The major factors individually reported to be associated with an increased frequency of CDKN2A mutations are increased number of patients with melanoma in a family, early age at melanoma diagnosis, and family members with multiple primary melanomas (MPM) or pancreatic cancer. Methods: These four features were examined in 385 families with ⩾3 patients with melanoma pooled by 17 GenoMEL groups, and these attributes were compared across continents. Results: Overall, 39% of families had CDKN2A mutations ranging from 20% (32/162) in Australia to 45% (29/65) in North America to 57% (89/157) in Europe. All four features in each group, except pancreatic cancer in Australia (p = 0.38), individually showed significant associations with CDKN2A mutations, but the effects varied widely across continents. Multivariate examination also showed different predictors of mutation risk across continents. In Australian families, ⩾2 patients with MPM, median age at melanoma diagnosis ⩽40 years and ⩾6 patients with melanoma in a family jointly predicted the mutation risk. In European families, all four factors concurrently predicted the risk, but with less stringent criteria than in Australia. In North American families, only ⩾1 patient with MPM and age at diagnosis ⩽40 years simultaneously predicted the mutation risk. Conclusions: The variation in CDKN2A mutations for the four features across continents is consistent with the lower melanoma incidence rates in Europe and higher rates of sporadic melanoma in Australia. The lack of a pancreatic cancer–CDKN2A mutation relationship in Australia probably reflects the divergent spectrum of mutations in families from Australia versus those from North America and Europe. GenoMEL is exploring candidate host, genetic and/or environmental risk factors to better understand the variation observed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Cancer Epidemiology and Prevention
(2006) · doi:10.1093/acprof:oso/9780195149616.001.0001 · Cited by 3,369
Germline p16 mutations in familial melanoma
Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Tucker, M. A., & Dracopoli, N. C. (1994) · Nature Genetics · doi:10.1038/ng0994-15 · Cited by 977
Self-citationIncreased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds with p16INK4Mutations
Goldstein, A. M., Fraser, M. C., Struewing, J. P., Hussussian, C. J., Ranade, K., Zametkin, D. P., Fontaine, L. S., Organic, S. M., Dracopoli, N. C., Clark, W. H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331504 · Cited by 622
Self-citationTobacco control country profiles
Shafey, O., Dolwick, S., & Guindon, G. E. (2003) · Medical Entomology and Zoology · Cited by 504
Soufir, N. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.2.209 · Cited by 386
Vasen, H. F. A., Gruis, N. A., Frants, R. R., van der Velden, P. A., Hille, E. T. M., & Bergman, W. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000915)87:6<809::aid-ijc8>3.0.co;2-u · Cited by 347
Self-citationBorg, A., Sandberg, T., Nilsson, K., Johannsson, O., Klinker, M., Masback, A., Westerdahl, J., Olsson, H., & Ingvar, C. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1260 · Cited by 345
Genetics of melanoma predisposition
Hayward, N. K. (2003) · Oncogene · doi:10.1038/sj.onc.1206445 · Cited by 321
Self-citationHomozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds
Gruis, N. A., van der Velden, P. A., Sandkuijl, L. A., Prins, D. E., Weaver-Feldhaus, J., Kamb, A., Bergman, W., & Frants, R. R. (1995) · Nature Genetics · doi:10.1038/ng0795-351 · Cited by 310
Self-citationCDKN2A Mutations in Multiple Primary Melanomas
Monzon, J., Liu, L., Brill, H., Goldstein, A. M., Tucker, M. A., From, L., McLaughlin, J., Hogg, D., & Lassam, N. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381305 · Cited by 264
Self-citationKefford, R. F., Newton Bishop, J. A., Bergman, W., & Tucker, M. A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3245 · Cited by 224
Self-citationLifetime Risk of Melanoma in CDKN2A Mutation Carriers in a Population-Based Sample
Begg, C. B., Orlow, I., Hummer, A. J., Armstrong, B. K., Kricker, A., Marrett, L. D., Millikan, R. C., Gruber, S. B., Anton-Culver, H., Zanetti, R., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji312 · Cited by 213
CDKN2A Variants in a Population-Based Sample of Queensland Families With Melanoma
Aitken, J., Welch, J., Duffy, D., Milligan, A., Green, A., Martin, N., & Hayward, N. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.5.446 · Cited by 200
Self-citationGenotype-Phenotype Relationships in U.S. Melanoma-Prone Families With CDKN2A and CDK4 Mutations
Goldstein, A. M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.12.1006 · Cited by 192
Self-citationA melanoma-associated germline mutation in exon 1β inactivates p14ARF
Rizos, H., Puig, S., Badenas, C., Malvehy, J., Darmanian, A. P., Jiménez, L., Milà, M., & Kefford, R. F. (2001) · Oncogene · doi:10.1038/sj.onc.1204728 · Cited by 171
Self-citationSystemic cancer and the FAMMM syndrome
Bergman, W., Watson, P., de Jong, J., Lynch, H., & Fusaro, R. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.209 · Cited by 160
Self-citationEvidence that haploinsufficiency of Ptch leads to medulloblastoma in mice
Zurawel, R. H., Allen, C., Wechsler‐Reya, R. J., Scott, M. P., & Raffel, C. (2000) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(200005)28:1<45::aid-gcc6>3.0.co;2-f · Cited by 155
Platz, A., Hansson, J., Månsson‐Brahme, E., Lagerlöf, B., Linder, S., Ringborg, U. K., Lundqvist, E., Sevigny, P., & Inganäs, M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.10.697 · Cited by 153
Self-citationRole of the CDKN2A Locus in Patients With Multiple Primary Melanomas
Puig, S., Malvehy, J., Bádenas, C., Ruiz, A., Jiménez, D., Cuéllar, F., Azón, A., González, U., CASTEL, T., Campoy, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.034 · Cited by 147
Self-citationMutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds
Walker, G. J., Hussussian, C. J., Flores, J. F., Glendening, M. J., Haluska, F. G., Dracopoli, N. C., Hayward, N. K., & Fountain, J. W. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.10.1845 · Cited by 141
Self-citationFamilial melanoma, pancreatic cancer and germline CDKN2A mutations
Goldstein, A. M. (2004) · Human Mutation · doi:10.1002/humu.9247 · Cited by 130
Self-citationHolland, E. A., Schmid, H., Kefford, R. F., & Mann, G. J. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199908)25:4<339::aid-gcc5>3.0.co;2-h · Cited by 122
Self-citationGenotype/Phenotype and Penetrance Studies in Melanoma Families with Germline CDKN2A Mutations
Newton‐Bishop, J., Wachsmuth, R. C., Harland, M., Bataille, V. A., Pinney, E., Mack, P., Baglietto, L., Cuzick, J. M., & Bishop, D. T. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00823.x · Cited by 120
Self-citationChaudru, V., Chompret, A., Paillerets, B. B., Spatz, A., Avril, M.-F., & Démenais, F. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh136 · Cited by 105
Self-citationAnalysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds.
Holland, E. A., Beaton, S. C., Becker, T. M., Grulet, O., Peters, B. A., Rizos, H., Kefford, R. F., & Mann, G. J. (1995) · PubMed · Cited by 101
Self-citationNovel germline p16 mutation in familial malignant melanoma in southern Sweden.
Borg, Å., Johannsson, U., Jóhannsson, Ó. Þ., Häkansson, S., Westerdahl, J., Måsbäck, A., Olsson, H. L., & Ingvar, C. (1996) · PubMed · Cited by 101
Characterization of ligurian melanoma families and risk of occurrence of other neoplasia
Ghiorzo, P., Ciotti, P., Mantelli, M., Heouaine, A., Queirolo, P., Rainero, M. L., Ferrari, C., Santi, P. L., Marchi, R. D., Farris, A., et al. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991112)83:4<441::aid-ijc2>3.0.co;2-r · Cited by 88
Self-citationPancreatic Carcinoma Surveillance in Patients With Familial Melanoma
Parker, J. F., Florell, S. R., Alexander, A., DiSario, J. A., Shami, P. J., & Leachman, S. A. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.8.1019 · Cited by 88
Self-citationAnalysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds
Flores, J. F., Pollock, P. M., Walker, G. J., Glendening, J. M., Lin, A. H.-T., Palmer, J. M., Walters, M. K., Hayward, N. K., & Fountain, J. W. (1997) · Oncogene · doi:10.1038/sj.onc.1201470 · Cited by 84
Self-citationCDKN2A Germline Mutations in U.K. Patients with Familial Melanoma and Multiple Primary Melanomas
MacKie, R. M., Andrew, N., Lanyon, W. G., & Connor, J. M. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00267.x · Cited by 84
Self-citationFamilial Melanoma and Pancreatic Cancer
Ciotti, P., Strigini, P., & Bianchi-Scarrà, G. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602153340714 · Cited by 68
Ruiz, A., Puig, S., Malvehy, J., Lázaro, C., Lynch, M., Giménez‐Arnau, A. M., Puig, L., Sánchez-Conejo, J., Estivill, X., & CASTEL, T. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.6.490 · Cited by 66
Self-citationGermline CDKN2A Mutations in Childhood Melanoma
Whiteman, D. C., Milligan, A., Welch, J., Green, A. C., & Hayward, N. K. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.19.1460 · Cited by 63
Self-citationMutation testing in melanoma families: INK4A, CDK4 and INK4D
Newton‐Bishop, J., Harland, M., Bennett, D. C., Bataille, V. A., Goldstein, A. M., Tucker, M. A., Ponder, B. A. J., Cuzick, J. M., Selby, P., & Bishop, D. T. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690354 · Cited by 61
Self-citationPopulation-Based Prevalence of CDKN2A Mutations in Utah Melanoma Families
Eliason, M. J., Larson, A. A., Florell, S. R., Zone, J. J., Cannon‐Albright, L., Samlowski, W. E., & Leachman, S. A. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700094 · Cited by 60
Self-citationPlatz, A., Hansson, J., & Ringborg, U. K. (1998) · International Journal of Cancer · Cited by 45
Self-citationOpitz, S., Käsmann‐Kellner, B., Kaufmann, M., SCHWINGER, E., & Zühlke, C. (2004) · Human Mutation · doi:10.1002/humu.9248 · Cited by 45
CDKN2A as a uveal and cutaneous melanoma susceptibility gene
Kannengiesser, C., Avril, M., Spatz, A., Laud, K., Lenoir, G., & Paillerets, B. B. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10286 · Cited by 44
Genetic susceptibility in familial melanoma from northeastern Italy
Landi, M. T., Goldstein, A. M., Tsang, S., Munroe, D. J., Modi, W., Ter‐Minassian, M., Steighner, R., Dean, M. C., Metheny, N., Staats, B. J., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.016907 · Cited by 44
Self-citationCytogenetic and molecular studies of the Philadelphia translocation in myelodysplastic syndromes
Verhoef, G. E. G., Meeus, P., Stul, M. S., Mecucci, C., Cassiman, J. J., BERGHE, H. V. D., & Boogaerts, M. A. (1992) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(92)90209-q · Cited by 36
MELPREDICT: a logistic regression model to estimate CDKN2A carrier probability
Niendorf, K. B., Goggins, W., Yang, G., Tsai, K. Y., Shennan, M., Bell, D. W., Sober, A. J., Hogg, D., & Tsao, H. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.032441 · Cited by 34
Self-citationHashemi, J., Linder, S. T., Platz, A., & Hansson, J. (1999) · Melanoma Research · doi:10.1097/00008390-199902000-00004 · Cited by 29
Self-citationYakobson, E., Eisenberg, S., Isacson, R., Halle, D., Levy‐Lahad, E., Catane, R., Safro, M. G., Sobolev, V. M., Huot, T. J. G., Peters, G. G., et al. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200961 · Cited by 28
Self-citationThe Dutch FAMMM family material: Clinical and genetic data
Bergman, W., Gruis, N. A., & Frants, R. R. (1992) · Cytogenetics and Cell Genetics · doi:10.1159/000133232 · Cited by 26
Self-citationRizos, H., Becker, T. M., Holland, E. A., Kefford, R. F., & Mann, G. J. (1997) · Oncogene · doi:10.1038/sj.onc.1201217 · Cited by 23
Self-citationLang, J., Boxer, M., & Mackie, R. M. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06846.x · Cited by 19
Self-citationA Novel Methionine-53-Valine Mutation of p16 in a Hereditary Melanoma Kindred
Yang, G., Niendorf, K. B., & Tsao, H. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23400.x · Cited by 8
Self-citation
Cited by
Shain, A. H., & Bastian, B. C. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.37 · Cited by 896
Canto, M. I., Harinck, F., Hruban, R. H., Offerhaus, G. J., Poley, J.-W., Kamel, I., Nio, Y., Schulick, R. S., Bassi, C., Kluijt, I., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303108 · Cited by 784
Oncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice
Dhomen, N., Reis-Filho, J. S., da Rocha Dias, S., Hayward, R., Savage, K., Delmas, V., Larue, L., Pritchard, C., & Marais, R. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.02.022 · Cited by 594
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma
Yokoyama, S., Woods, S. L., Boyle, G. M., Aoude, L. G., MacGregor, S., Zismann, V., Gartside, M., Cust, A. E., Haq, R., Harland, M., et al. (2011) · Nature · doi:10.1038/nature10630 · Cited by 484
Self-citationGenome-wide association study identifies three loci associated with melanoma risk
Bishop, D. T., Demenais, F., Iles, M. M., Harland, M., Taylor, J. C., Corda, E., Randerson-Moor, J., Aitken, J. F., Avril, M.-F., Azizi, E., et al. (2009) · Nature Genetics · doi:10.1038/ng.411 · Cited by 462
Self-citation
Metadata
- Authors
- Goldstein, A. M., Chan, M., Harland, M., Hayward, N. K., Demenais, F., Timothy Bishop, D., Azizi, E., Bergman, W., Bianchi-Scarra, G., Bruno, W., Calista, D., Cannon Albright, L. A., Chaudru, V., Chompret, A., Cuellar, F., Elder, D. E., Ghiorzo, P., Gillanders, E. M., Gruis, N. A., Hansson, J., Hogg, D., Holland, E. A., Kanetsky, P. A., Kefford, R. F., Teresa Landi, M., Lang, J., Leachman, S. A., MacKie, R. M., Magnusson, V., Mann, G. J., Newton Bishop, J., Palmer, J. M., Puig, S., Puig-Butille, J. A., Stark, M., Tsao, H., Tucker, M. A., Whitaker, L., & Yakobson, E.
- Venue
- Journal of Medical Genetics
- Publisher
- BMJ
- Published
- 2006-08-11
- Volume
- 44
- Issue
- 2
- Pages
- 99-106
- ISSN
- 0022-2593 (ISSN-L)
- 1468-6244
- OpenAlex
- W2131906164
- Cited by
- 453
- References
- 48
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.